Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (281-290 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Diabetes Care|February 13, 2008
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyStephane De Wit, Caroline A Sabin, Rainer Weber, et al.
AIDS (London, England)|January 9, 2022
Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the NetherlandsCas J Isfordink, Colette Smit, Anders Boyd, et al.
Elife|August 13, 2021
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapyAlexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra, et al.
The Journal of Infectious Diseases|December 20, 2021
Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIVMyrthe L Verburgh, Anders Boyd, Ferdinand W N M Wit, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
AIDS (London, England)|May 11, 2018
HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapyMaartje Dijkstra, Rik H W van Lunsen, Katherine W Kooij, et al.
The Journal of Infectious Diseases|November 13, 2018
Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged IndividualsSebastiaan O Verboeket, Ferdinand W Wit, Greg D Kirk, et al.
Pageof 51

Showing results (281-290 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Diabetes Care|February 13, 2008
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyStephane De Wit, Caroline A Sabin, Rainer Weber, et al.
AIDS (London, England)|January 9, 2022
Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the NetherlandsCas J Isfordink, Colette Smit, Anders Boyd, et al.
Elife|August 13, 2021
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapyAlexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra, et al.
The Journal of Infectious Diseases|December 20, 2021
Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIVMyrthe L Verburgh, Anders Boyd, Ferdinand W N M Wit, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
AIDS (London, England)|May 11, 2018
HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapyMaartje Dijkstra, Rik H W van Lunsen, Katherine W Kooij, et al.
The Journal of Infectious Diseases|November 13, 2018
Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged IndividualsSebastiaan O Verboeket, Ferdinand W Wit, Greg D Kirk, et al.
Pageof 51